Stock Research for AEZS

AEZS

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

AEZS Stock Chart & Research Data

The AEZS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AEZS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AEZS Due diligence Resources & Stock Charts

The AEZS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AEZS Detailed Price Forecast - CNN Money CNN View AEZS Detailed Summary - Google Finance
Yahoo View AEZS Detailed Summary - Yahoo! Finance Zacks View AEZS Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View AEZS Trends & Analysis - Trade-Ideas Barrons View AEZS Major Holders - Barrons
NASDAQ View AEZS Call Transcripts - NASDAQ Seeking View AEZS Breaking News & Analysis - Seeking Alpha
Spotlight View AEZS Annual Report - CompanySpotlight.com OTC Report View AEZS OTC Short Report - OTCShortReport.com
TradeKing View AEZS Fundamentals - TradeKing Charts View AEZS SEC Filings - Bar Chart
WSJ View Historical Prices for AEZS - The WSJ Morningstar View Performance/Total Return for AEZS - Morningstar
MarketWatch View the Analyst Estimates for AEZS - MarketWatch CNBC View the Earnings History for AEZS - CNBC
StockMarketWatch View the AEZS Earnings - StockMarketWatch MacroAxis View AEZS Buy or Sell Recommendations - MacroAxis
Bullish View the AEZS Bullish Patterns - American Bulls Short Pains View AEZS Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View AEZS Stock Mentions - StockTwits PennyStocks View AEZS Stock Mentions - PennyStockTweets
Twitter View AEZS Stock Mentions - Twitter Invest Hub View AEZS Investment Forum News - Investor Hub
Yahoo View AEZS Stock Mentions - Yahoo! Message Board Seeking Alpha View AEZS Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for AEZS - SECform4.com Insider Cow View Insider Transactions for AEZS - Insider Cow
CNBC View AEZS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AEZS - OTC Markets
Yahoo View Insider Transactions for AEZS - Yahoo! Finance NASDAQ View Institutional Holdings for AEZS - NASDAQ


Stock Charts

FinViz View AEZS Stock Insight & Charts - FinViz.com StockCharts View AEZS Investment Charts - StockCharts.com
BarChart View AEZS Stock Overview & Charts - BarChart Trading View View AEZS User Generated Charts - Trading View




Latest Financial News for AEZS


Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris
Posted on Thursday March 28, 2024

TORONTO and EDMONTON, Alberta, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna") and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro”) are pleased to announce that the Court of King's Bench of Alberta has issued a final order approving the arrangement described in the previously announced definitive agreement to combine the operations of Ceapro and Aeterna in an all-stock merger of equals transaction (the “Transaction”). The parties anticipate comple


Aeterna Zentaris (AEZS) Reports Q4 Loss, Tops Revenue Estimates
Posted on Wednesday March 27, 2024

AEterna Zentaris (AEZS) delivered earnings and revenue surprises of -19.59% and 2,925%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?


Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
Posted on Wednesday March 27, 2024

- Company confirms successful completion of enrollment in the pivotal DETECT Phase 3 trial - Company ended the year with $34.0 million in cash, expected to fund operations through 2024 and into 2025 - All-stock merger of equals transaction with Ceapro, Inc. expected to close in the second quarter of 2024 TORONTO, ONTARIO, March 27, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercia


Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
Posted on Tuesday March 12, 2024

TORONTO and EDMONTON, Alberta, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna”) and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro”) are pleased to announce that securityholders of both biopharmaceutical development companies approved the all-stock merger of equals transaction (the “Transaction”) at their respective special meetings held today. The specific voting results were as follows: Aeterna shareholders approved the Transaction with the follo


Stock Market & Investing Books

Enter a stock symbol to view the stock details.